TBPPM Course 2024 Wraps Up with a Flourishing Cohort of Inspired Alumni
Published on July 5, 2024
The TBPPM Course 2024, held from June 3-7, marked the third successful cohort and the second time it was offered as part of the McGill Summer Institute. With 82 participants from 25 countries, including 88% from high TB burden regions, this year's course continued to build on its legacy of fostering a global, interactive learning environment.
Course Highlights:
- Day 1: The course began with engaging lectures, insightful questions, and impressive assignment work, showcasing participants' extensive experience and knowledge.
- Day 2: The focus was on Planning and Quality of Care in TB-PPM. Key takeaways included the challenges of ensuring quality TB care among private providers and the critical role of Universal Health Coverage (UHC) in leaving no one behind. Insights from Indonesia's PPM strategy and shared challenges across countries enriched the discussions.
- Day 3: Policy and Financing in TB-PPM were the main topics. Discussions highlighted the complexities of financing, government structures, and innovative strategies. A panel discussion provided valuable perspectives on integrating TB services into social health insurance and contracting intermediary organizations.
- Day 4: Featured practical presentations on engaging private providers, with case studies from Nigeria and South Africa. Monitoring and data management were key themes, with insights from WHO's PPM dashboards and India's monitoring experiences. A lively public-private dialogue capped off the day, emphasizing the need for trust and understanding in partnerships.
- Day 5: The course concluded with a focus on practical applications and reinforcing the need for win-win solutions in TB care through collaboration and interaction.
The TBPPM Course 2024 demonstrated the power of global collaboration, diverse expertise, and innovative approaches in tackling TB. We thank all participants, faculty, and the McGill Summer Institute for their invaluable contributions and look forward to continuing our efforts to end TB together.